Alexander Martinez-Forte

Director, Quantitative Research & Strategy·RA Capital Management

Bio

Professional summary

Alex Martinez-Forte is Director, Quantitative Research & Strategy at RA Capital Management. His firm bio says he leads quantitative analyses that support investment decisions and inform portfolio management. Before RA Capital, he worked at Mirai Advisory on financial risk, data science and machine learning algorithms for banks, and earlier was a Financial Analyst at Wainwright Investment Counsel.

Background

Career, education, and skills

Career history

RA Capital ManagementDirector, Quantitative Research & StrategyPresent
Mirai AdvisoryFinancial risk and data science specialist
Wainwright Investment CounselFinancial Analyst

Education

UMass LowellBA with triple major in Finance, Economics, and Math

Other partners at RA Capital Management

12 more profiles

View firm →

Abigail (Lauterbach) Schmitz

Senior Associate

RA Capital Management

TechAtlas senior associate evaluating biotech opportunities and competitive landscapes.

biotech diligencecompetitive landscapesportfolio strategyTechAtlastherapeutics

Adam Prince, MD

Senior Associate, Strategic Initiatives

RA Capital Management

RA Capital TechAtlas senior associate with cardiology and medical training.

biotech diligencecardiologyhealth innovationportfolio strategyTechAtlas

Alana MacDonald, Ph.D.

Senior Associate

RA Capital Management

Senior TechAtlas associate focused on biotech diligence, landscapes, and portfolio strategy.

biotechnologycompetitive landscapesportfolio strategyTechAtlastherapeutics

Alejandro Sevilla

Associate

RA Capital Management

Planetary Health associate focused on climate-tech landscapes and investment evaluation.

advanced batteriesclimate technologycompetitive landscapesenergy storageplanetary health

Alex Miller

Senior Associate, Venture

RA Capital Management

Venture senior associate focused on biotech diligence and portfolio strategy.

biotechnologyprogram strategyTechAtlastherapeuticsventure investing

Alex T. Zhang

Vice President, Structured Capital

RA Capital Management

Structured Capital VP focused on healthcare and life-sciences credit investments.

commercial-stage healthcarehealthcare creditlife sciencesprivate creditstructured capital

Allison Harrigan

Senior Director Corporate Development

RA Capital Management

Raven corporate development leader focused on biotech company creation.

Biotech strategyBusiness developmentCompany creationCorporate developmentDrug discovery

Alyssa Larson

Director, Healthcare Specialist - Investor Relations

RA Capital Management

TechAtlas director supporting healthcare diligence and investor relations.

BiochemistryCompetitive landscapesHealthcare diligenceInvestor relationsTechAtlas

Ami Thakrar, PhD

Associate

RA Capital Management

TechAtlas associate focused on biotech diligence and program strategy.

biotechnologycompetitive landscapesmedical engineeringprogram strategyTechAtlas

Anish K. More

Vice President, Corporate Development

RA Capital Management

Raven corporate-development VP focused on investment evaluation and NewCo creation.

company creationcorporate developmenthealthcare servicesNewCosRaven

Anurag Kondapalli

Principal

RA Capital Management

Principal investing across public and private healthcare technology and services companies.

healthcare serviceshealthcare technologyprivate investmentspublic investmentsstructured growth capital

Breanna O'Reilly

Analyst

RA Capital Management

Investment analyst focused on biotech due diligence.

biomedical engineeringbiotechnologydue diligenceinvestment analysistherapeutics

See something out of date?

Suggest a correction — our team reviews every edit.

Improve this profile